NCT03154827 2024-09-05Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML)BioLineRx, Ltd.Phase 1/2 Terminated1 enrolled 6 charts